Concussion Market Research Reveals Strong 5% CAGR Outlook Through 2030

The concussion market is gaining significant attention as advancements in technology and healthcare awareness drive demand for improved diagnostic and treatment options. With growing emphasis on brain health and innovative medical solutions, this sector is set to experience substantial growth and transformation in the coming years.

Forecasted Market Size and Growth Trajectory of the Concussion Market
The concussion market is projected to expand steadily, reaching a valuation of $10.43 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 5.0% during the forecast period. Key factors contributing to this upward trend include the rising use of AI-assisted concussion diagnostics, increased focus on long-term monitoring of brain health, the broadening of remote patient monitoring technologies, and escalating investments in neurorehabilitation. Alongside these, the demand for tailored concussion management strategies also plays an important role. Emerging trends set to influence the market include greater adoption of advanced neuroimaging, digital cognitive assessment platforms, wearable monitoring devices, multidisciplinary rehabilitation techniques, and prioritizing early and precise diagnosis.

The concussion market size has grown steadily in recent years. It will grow from $8.2 billion in 2025 to $8.58 billion in 2026 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to increasing incidence of sports-related injuries, rising awareness of traumatic brain injuries, expansion of diagnostic imaging availability, growth of rehabilitation services, improved clinical assessment protocols.

Download a free sample of the concussion market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11888&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Companies Steering the Concussion Market
Several prominent players hold a significant position in the concussion industry, including Pfizer Inc., Novartis AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Viatris Inc., Zydus Lifesciences Ltd., Integra LifeSciences Corporation, Nihon Kohden Corporation, Raumedic AG, Lupin Limited, NeuroPace Inc., Compumedics Limited, NeuroLogica Corporation, Neural Analytics Inc., NovaSignal Corp., Back Bay Life Science Advisors, BrainScope Company Inc., Neuro Kinetics Inc., ImPACT Applications Inc., NanoDx Inc., Neuren Pharmaceuticals Limited, Advanced Brain Monitoring Inc., ElMindA Ltd., NeurOptics Inc., InfraScan Inc., Neuro Assessment Systems Inc., NeuroTrauma Sciences LLC, SyncThink Inc., Oxeia Biopharmaceuticals Inc., Oculogica Inc., Banyan Biomarkers Inc., Emotiv Inc., and BioDirection Inc.

A notable development occurred in August 2023 when Oxeia Biopharmaceuticals Inc., a clinical-stage biotech firm based in the US, acquired SUN11031-a synthetic human ghrelin-from Kinemed Inc. This acquisition is expected to lead to the development of OXE103, a treatment aimed at concussions and other acute neurotrauma. Kinemed Inc. is recognized as a pharmaceutical research and development company also based in the US.

View the full concussion market report:
https://www.thebusinessresearchcompany.com/report/concussion-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Shaping the Future of the Concussion Market
Innovation is at the forefront of the concussion market, with companies focused on rapid point-of-care biomarker blood tests that provide timely and accurate concussion detection. These tests, conducted near the patient, analyze specific blood markers to assist healthcare providers in making immediate diagnostic and treatment decisions. For example, in April 2024, Abbott Laboratories introduced a whole blood rapid test for traumatic brain injury (TBI) on its portable i-STAT Alinity platform. This breakthrough enables clinicians to conduct concussion assessments at the bedside and receive lab-quality results within 15 minutes. Previously, such tests required plasma or serum samples to be sent to labs, but this new advancement shortens evaluation time significantly, potentially reducing reliance on CT scans and improving prompt decision-making for urgent care and other medical settings.

Detailed Segmentation in the Concussion Market Report
The concussion market is categorized into several key segments to provide comprehensive insights:
1) By Assessment:
- Diagnosis
- Treatment
2) By Device:
- Imaging Devices
- Magnetic Resonance Imaging (MRI) Devices
- X-Ray
- Computed Tomography
- Monitoring Devices
- Other Devices
3) By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Medical Camps
- Other End-Users

Within these, more specific subsegments include:
- Diagnosis: Clinical Assessments and Imaging Techniques
- Treatment: Pharmacological Treatments, Cognitive Rehabilitation, and Physical Therapy

This detailed classification helps the market understand where the greatest needs and opportunities lie across the continuum of concussion care.

What's new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.